Skip to content

Comparing QLB Type I Block to Intraperitoneal Instillation Added to Wound Infiltration for Postoperative Cesarian Pain

Comparing Quadratus Lumborum Type 1 Block to The Combination Of Intraperitoneal Instillation Of Local Anesthetics And Wound Infiltration For Postoperative Pain After Cesarean Delivery: A Prospective Double-Blind Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06129032
Enrollment
40
Registered
2023-11-13
Start date
2023-11-01
Completion date
2025-06-25
Last updated
2023-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

This study aimed to compare the efficacy of local anaesthetic infiltration into all layers of the anterior abdominal wall with peritoneal instillation and QLB type I for pain reduction in women undergoing elective cesarean section under spinal anaesthesia.

Detailed description

This study will be conducted as a prospective randomized, controlled, double-blind trial following the approval of the ethical committee at Atatürk University Medical Faculty Hospital and after obtaining written consent from the participating patients. The study will include pregnant women aged 18 to 50 with American Society of Anesthesiologists (ASA) II classification, full-term and singleton pregnancies planned to undergo cesarean section using Pfannenstiel incision with spinal anaesthesia. Using a randomisation procedure, the participants will be allocated into two equal groups: Group IPLA+ LWI and Group QLB.

Interventions

PROCEDUREWound infiltration (LWI) + Intraperitoneal local anaesthetic (IPLA) instillation

a solution containing 20 ml of 0.5% bupivacaine, 20 ml of 2% lidocaine and 1:200,000 epinephrine with a total volume of 40 ml. A volume of 10 millilitres of the solution will be administered through the drip technique into each of the four quadrants of the uterus prior to the subsequent closure of the parietal peritoneum or fascia. A total volume of 10 ml of the solution will be administered through infiltration at the edges of the rectus aponeurosis, while the remaining 20 ml will be infiltrated subcutaneously into the incision

quadratus lumborum type 1 block will be applied bilaterally on both sides with a total of 40 ml of solution containing 20 ml of 0.5% bupivacaine + 20 ml of 2% lidocaine + 1:200.000 epinephrine, under ultrasound guidance

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* aged between 18 to 50 * American Society of Anesthesiologists (ASA) II classification, * full-term and singleton pregnancies planned to undergo cesarean section * using Pfannenstiel incision * spinal anaesthesia

Exclusion criteria

* whom neuraxial anaesthesia is contraindicated, * those who are allergic to drugs to be used in the study, * who refused to participate in the study, * those with BMI\>35 kg/m2, * ASA score ≥3 or higher, * diabetes mellitus, preeclampsia, cardiovascular disease, chronic pain and neuropathic pain, * individuals who have received opioids during the surgical procedure for intraoperative pain, * patients who have undergone abdominal surgery, * patients who have experienced a transition from spinal anaesthesia to general anaesthesia due to failure, * those with excessive bleeding during the operation, * who have uterine atony, * those who have a drain placed in the area to be infiltrated, * those who cannot understand the Visual Analog Scale (VAS), * who have a history of drug addiction and psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
difference between total opioid consumption in 24 hourspostoperative 24 hoursThe study will involve monitoring the intake of opioids at specific time intervals (2nd, 4th, 6th, 12th, and 24th hours), calculating the cumulative opioid consumption until the 24th hour

Countries

Turkey (Türkiye)

Contacts

Primary ContactAyşenur Dostbil
adostbil@hotmail.com+905333677796
Backup ContactAyşenur Dostbil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026